Haemodynamic effects of oral molsidomine in pump failure complicating myocardial infarction. 1984

S Drajer, and H Cercós, and H Torres, and A Vazquez, and J L Cohn, and N Romero, and G Faerman, and S Soifer, and C M Nijensohn

Haemodynamic monitoring, using a Swan-Ganz balloon catheter, was done in 14 patients with pump failure associated with acute myocardial infarction, before and for 8 h after single 6 mg oral dose of molsidomine. The following changes effects were found: HR fell by 1.6 to 4.7% (significant at 4th hour; p less than 0.05); SBP was 8.4% lower after 1 h (p less than 0.05); PCP was decreased by approximately 30%, a significant effect that lasted for 8 hours (p less than 0.002). CI did not change significantly, although individual analysis showed it to have increased in 6 out of 12 cases. Stroke volume index was increased by about 6% (significant after 1 h, p less than 0.025). The left ventricular stroke work index also increased from 9.8 to 24.5% (significant after 1 and 4 h, p less than 0.01 and 0.025). These findings show the beneficial haemodynamic effects of molsidomine in pump failure complicating acute myocardial infarction.

UI MeSH Term Description Entries
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D008981 Molsidomine A morpholinyl sydnone imine ethyl ester, having a nitrogen in place of the keto oxygen. It acts as NITRIC OXIDE DONORS and is a vasodilator that has been used in ANGINA PECTORIS. Morsydomine,Corpea,Corvaton,Duracoron,Fali-Cor,Korvatone,MTW-Molsidomin,Molsi 1A Pharma,Molsi-AZU,Molsi-Puren,Molsibeta,Molsicor,Molsidain,Molsidomin,Molsidomin Heumann,Molsidomin Stada,Molsidomin Von Ct,Molsidomin-Ratiopharm,Molsihexal,Molsiket,SIN-10,Sydnopharm,Fali Cor,Heumann, Molsidomin,MTW Molsidomin,Molsi AZU,Molsi Puren,Molsidomin Ratiopharm,SIN 10,SIN10,Von Ct, Molsidomin
D009203 Myocardial Infarction NECROSIS of the MYOCARDIUM caused by an obstruction of the blood supply to the heart (CORONARY CIRCULATION). Cardiovascular Stroke,Heart Attack,Myocardial Infarct,Cardiovascular Strokes,Heart Attacks,Infarct, Myocardial,Infarction, Myocardial,Infarctions, Myocardial,Infarcts, Myocardial,Myocardial Infarctions,Myocardial Infarcts,Stroke, Cardiovascular,Strokes, Cardiovascular
D010069 Oxadiazoles Compounds containing five-membered heteroaromatic rings containing two carbons, two nitrogens, and one oxygen atom which exist in various regioisomeric forms. Oxadiazole
D002302 Cardiac Output The volume of BLOOD passing through the HEART per unit of time. It is usually expressed as liters (volume) per minute so as not to be confused with STROKE VOLUME (volume per beat). Cardiac Outputs,Output, Cardiac,Outputs, Cardiac
D005260 Female Females
D006328 Cardiac Catheterization Procedures in which placement of CARDIAC CATHETERS is performed for therapeutic or diagnostic procedures. Catheterization, Cardiac,Catheterization, Heart,Heart Catheterization,Cardiac Catheterizations,Catheterizations, Cardiac,Catheterizations, Heart,Heart Catheterizations
D006333 Heart Failure A heterogeneous condition in which the heart is unable to pump out sufficient blood to meet the metabolic need of the body. Heart failure can be caused by structural defects, functional abnormalities (VENTRICULAR DYSFUNCTION), or a sudden overload beyond its capacity. Chronic heart failure is more common than acute heart failure which results from sudden insult to cardiac function, such as MYOCARDIAL INFARCTION. Cardiac Failure,Heart Decompensation,Congestive Heart Failure,Heart Failure, Congestive,Heart Failure, Left-Sided,Heart Failure, Right-Sided,Left-Sided Heart Failure,Myocardial Failure,Right-Sided Heart Failure,Decompensation, Heart,Heart Failure, Left Sided,Heart Failure, Right Sided,Left Sided Heart Failure,Right Sided Heart Failure
D006439 Hemodynamics The movement and the forces involved in the movement of the blood through the CARDIOVASCULAR SYSTEM. Hemodynamic

Related Publications

S Drajer, and H Cercós, and H Torres, and A Vazquez, and J L Cohn, and N Romero, and G Faerman, and S Soifer, and C M Nijensohn
January 1987, Journal of cardiovascular pharmacology,
S Drajer, and H Cercós, and H Torres, and A Vazquez, and J L Cohn, and N Romero, and G Faerman, and S Soifer, and C M Nijensohn
June 1977, Annals of clinical research,
S Drajer, and H Cercós, and H Torres, and A Vazquez, and J L Cohn, and N Romero, and G Faerman, and S Soifer, and C M Nijensohn
January 1986, Journal of cardiovascular pharmacology,
S Drajer, and H Cercós, and H Torres, and A Vazquez, and J L Cohn, and N Romero, and G Faerman, and S Soifer, and C M Nijensohn
April 1994, European heart journal,
S Drajer, and H Cercós, and H Torres, and A Vazquez, and J L Cohn, and N Romero, and G Faerman, and S Soifer, and C M Nijensohn
January 1979, The Medical clinics of North America,
S Drajer, and H Cercós, and H Torres, and A Vazquez, and J L Cohn, and N Romero, and G Faerman, and S Soifer, and C M Nijensohn
January 1985, Journal of cardiovascular pharmacology,
S Drajer, and H Cercós, and H Torres, and A Vazquez, and J L Cohn, and N Romero, and G Faerman, and S Soifer, and C M Nijensohn
January 1985, Zeitschrift fur Kardiologie,
S Drajer, and H Cercós, and H Torres, and A Vazquez, and J L Cohn, and N Romero, and G Faerman, and S Soifer, and C M Nijensohn
January 1978, Arzneimittel-Forschung,
S Drajer, and H Cercós, and H Torres, and A Vazquez, and J L Cohn, and N Romero, and G Faerman, and S Soifer, and C M Nijensohn
January 1987, Journal of cardiovascular pharmacology,
S Drajer, and H Cercós, and H Torres, and A Vazquez, and J L Cohn, and N Romero, and G Faerman, and S Soifer, and C M Nijensohn
June 1975, British heart journal,
Copied contents to your clipboard!